Abstract, Snapshot, Market Analysis & Market Definition: Platelet Rich Plasma (PRP) Market
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue. In 2017, P-PRP is the largest segment of PRP utilized globally and held more than 63% of market share in the global PRP market. Rich content of platelets and growth factors and conventional type of PRP are the key factors that contributed in the dominance of P-PRP segment. Meanwhile, L-PRF is anticipated to be the fastest growing segment during the forecast period from 2017 to 2025.
In 2019, the market size of Platelet Rich Plasma (PRP) is 210.8 million US$ and it will reach 444.5 million US$ in 2025, growing at a CAGR of 11.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Platelet Rich Plasma (PRP). This report studies the global market size of Platelet Rich Plasma (PRP), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Platelet Rich Plasma (PRP) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
Market Segmentation, Outlook & Regional Insights: Platelet Rich Plasma (PRP) Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
P-PRP
L-PRP
L-PRF
Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
Key Players, Recent Developments & Sector Viewpoints: Platelet Rich Plasma (PRP) Market
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Key Insights Covered: Exhaustive Platelet Rich Plasma (PRP) Market
1. Market size (sales, revenue and growth rate) of Platelet Rich Plasma (PRP) industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of Platelet Rich Plasma (PRP) industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Platelet Rich Plasma (PRP) industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Platelet Rich Plasma (PRP) industry.
Research Methodology: Platelet Rich Plasma (PRP) Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.